Between 1991 and 2012, the facilities that reported to the U.S. Environmental Protection Agency's Toxic Release Inventory (TRI) Program conducted 370,000 source reduction projects. We use this data set to conduct the first quasi-experimental retrospective evaluation of how implementing a source reduction (pollution prevention) project affects the quantity of toxic chemicals released to the environment by an average industrial facility. We use a differences-in-differences methodology, which measures how implementing a source reduction project affects a facility's releases of targeted chemicals, relative to releases of (a) other untargeted chemicals from the same facility, or (b) the same chemical from other facilities in the same industry. We find that the average source reduction project causes a 9-16% decrease in releases of targeted chemicals in the year of implementation. Source reduction techniques vary in effectiveness: for example, raw material modification causes a large decrease in releases, while inventory control has no detectable effect. Our analysis suggests that in aggregate, the source reduction projects carried out in the U.S. since 1991 have prevented between 5 and 14 billion pounds of toxic releases.
Pharmaceutical firms have reported that implementation of green chemistry practices in their manufacturing processes have significantly reduced the quantities of toxic chemicals they use, release to the environment, or otherwise manage as waste. Using the United States Environmental Protection Agency's (EPA's) Toxics Release Inventory (TRI) database and literature publications, we conducted research to assess this claim. Our analyses show that over the 2002 through 2011 timeframe the quantities of toxic chemicals reported annually by pharmaceutical manufacturing facilities to EPA's TRI Program as released to the environment or otherwise managed as waste have declined steadily and by more than 60%. The large reductions in the reported quantities are sector-wide, and it appears that factors such as outsourcing, production levels, regulations, shifts to other waste management practices, or TRI reporting characteristics by the larger pharmaceutical firms are not driving the decline. Our analyses, combined with the extensive evidence in the literature of green chemistry advances within the pharma sector, lead us to conclude that implementation of green chemistry practices is a major contributing factor to the large reductions we report herein. We believe the TRI, an easy-to-use pollution prevention tool used extensively for tracking environmental performance, is uniquely well-suited for assessing the progress made by different industry sectors or specific facilities therein in implementing green chemistry practices and the effectiveness that such practices have in preventing pollution: uses of the TRI that hitherto have not been reported. Moreover, our findings indicate that other pollutant release and transfer registers (PRTRs) may have the potential to be used for these purposes as well.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.